Bp Plc  (BP)
Other Ticker:  
Price: $35.8800 $-0.60 -1.645%
Day's High: $36.02 Week Perf: 0.22 %
Day's Low: $ 35.17 30 Day Perf: -9.58 %
Volume (M): 11,143 52 Wk High: $ 41.38
Volume (M$): $ 399,811 52 Wk Avg: $32.59
Open: $35.63 52 Wk Low: $25.37

 Market Capitalization (Millions $) 681,172
 Shares Outstanding (Millions) 18,985
 Employees -
 Revenues (TTM) (Millions $) 248,891
 Net Income (TTM) (Millions $) -1,357
 Cash Flow (TTM) (Millions $) 30,681
 Capital Exp. (TTM) (Millions $) 0

Bp Plc

   Company Address: 1 St James?s Square London 0
   Company Phone Number: (0) 20 7496 4000   Stock Exchange / Ticker: NYSE BP
   BP is expected to report next financial results on March 09, 2024.

Customers Net Income fell by BP's Customers Net Profit Margin fell to

-12.87 %

7.31 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
COP        1.1% 
CVX        2.44% 
MPC        0.84% 
PSX   -1.05%    
VLO        2.29% 
XOM        3.7% 
• View Complete Report

Aptose Biosciences Inc

As one of many corporations, the APTO announced also the fourth quarter of 2022 effort

The Biotechnology & Pharmaceuticals sector contributors continue to analyze the fourth quarter of 2022 numbers. Today those contributors observe operating shortfall of $-10.403 millions, from the company, which has not mentioned any revenue so far, for the own October to December 31 2022 financial reporting period.

Meta Materials Inc

The Top-line plunged at MMAT during the fourth quarter of 2022 earnings season

For the fiscal fourth quarter of 2022 MMAT decreased a loss per share of $-0.03 per share compare to $-0.22 a year prior and earnings per share improved from $-0.07 per share from the preceding financial reporting period.

Sales faded by -49.855 % to $1.45 millions from $2.88 millions in the comparable financial reporting period a year prior and sequentially Sales Tumbled by -41.135 % from $2.46 millions.

Aslan Pharmaceuticals Limited

Biotechnology & Pharmaceuticals company, decline in the operating behavior throughout the financial span ending fourth quarter of 2022

Trailing the big players in the Biotechnology & Pharmaceuticals sector, a few lesser known businesses are coming in with their earnings. ASLN mentioned it has reported operating deficit of $-47.882487 millions, for the fourth quarter of 2022.

First Seacoast Bancorp Inc

Deficit on Weak Sales the FSEA all along the fiscal span closing Dec 31 2022

For the fiscal fourth quarter of 2022 company slipped into deficit of $-0.28 per share compare to $0.07 a year prior and Income per Share fell from $0.08 per share from the prior financial reporting period.

Sales declined respectably by -13.143 % to $3.23 millions from $3.71 millions in the same financial reporting period a year prior and sequentially Sales fell by -23.488 % from $4.22 millions.

Pldt Inc

Pldt Inc announced contradictory earnings in the fourth quarter of 2022 earnings season, where Sales grew by 6.203 % to $3.92 billions relative to $3.70 billions on a year-over-year basis, while earnings per share dived by -60.36 % to $0.92 per share, as a comparison to $2.33 in the prior year reporting season.


Bp Plc's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

PALT's Profile

Stock Price

PALT's Financials

Business Description


Charts & Quotes

PALT's News


PALT's Competitors

Customers & Markets

Economic Indicators

PALT's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071